New Mexico, Missouri, Columbia Next for Review As comprehensive Centers; UCLA Decision In October
In Brief: HSAs Would Delay NCI Awards By Nine Months; Mary Lasker Names to Carter Health Group
Committee Kills Pay Raise Bill; Rauscher Probably Will Resign
Conferees Stalled On Money Bill, Running Out Of Time
NCAB Hung Up On removing $ 45 Million Limit For Core Grants
Obey Again – Now He’s Blasting NCI For Not Helping NIOSH
Abstracts Of Papers Presented By Breast Cancer Task Force
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Prediction markets now allow betting on clinical trial results, FDA decisions
It’s a high-risk bet: Insider trading, equipoise, integrity of research, public trust are at stake - Trump plans a 200% tariff on imported generic drugs by 2029, raising fears of cancer drug shortages
“There is a reason why generics have been exempt from all the tariffs until now,” Brookings economist warns - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Retraction is not refutation: Why chrono-immunotherapy still deserves scientific investigation
- FDA’s OCE publishes three final guidances to increase clinical trial enrollment
